Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial.

Research paper from Europe PMC. Evidence status: source reported.

Published

2017-03-13

Source reference

MED:28300506

DOI

10.1200/jco.2016.69.0677

Jurisdiction

Not assessed

Licence

Bibliographic metadata only; article rights retained

Mason MD, Clarke NW, James ND, Dearnaley DP, Spears MR, Ritchie AWS, Attard G, Cross W, Jones RJ, Parker CC, Russell JM, Thalmann GN, Schiavone F, Cassoly E, Matheson D, Millman R, Rentsch CA, Barber J, Gilson C, Ibrahim A, Logue J, Lydon A, Nikapota AD, O'Sullivan JM, Porfiri E, Protheroe A, Srihari NN, Tsang D, Wagstaff J, Wallace J, Walmsley C, Parmar MKB, Sydes MR, STAMPEDE Investigators. · J Clin Oncol · research-article; randomized controlled trial; journal article · Found via: ClinicalTrials.gov result publication

Source: https://europepmc.org/article/MED/28300506. Captured 2026-10-24.

Limitations: Listed by a ClinicalTrials.gov registration as a result publication of that study, and fetched by its PubMed ID. The registry's listing is the sponsor's statement; it does not confirm which data the paper used. Preprints may not be peer reviewed.